ATEC
Alphatec Holdings, Inc. · Healthcare · Medical Devices
Last
$7.49
−$0.26 (−3.35%) 4:00 PM ET
After hours $7.49 $0.00 (0.00%) 3:40 AM ET
Prev close $7.75
Open $7.81
Day high $7.97
Day low $7.42
Volume 2,855,174
Avg vol 4,229,047
Mkt cap
$1.19B
P/E ratio
-9.02
FY Revenue
$787.08M
EPS
-0.83
Gross Margin
70.18%
Sector
Healthcare
AI report sections
ATEC
Alphatec Holdings, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+5% (Above avg)
Vol/Avg: 1.05×
RSI
38.53 (Weak)
Weak (30–40)
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.01 Signal: 0.01
Short-Term
+0.10 (Strong)
MACD: -0.59 Signal: -0.69
Long-Term
+0.05 (Strong)
MACD: -1.19 Signal: -1.24
Intraday trend score 37.00

Latest news

ATEC 12 articles Positive: 2 Neutral: 1 Negative: 5
Negative GlobeNewswire Inc. • The Schall Law Firm
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating Alphatec Holdings for potential securities fraud following the company's May 5, 2026 Q1 earnings report, which revealed missed revenue estimates, lower deliveries than prior year, and reduced full-year 2026 guidance. The stock fell 31.7% on May 6, 2026, after the company admitted to failing to fulfill committed unit deliveries.

ATEC securities fraud shareholder litigation missed earnings revenue guidance stock decline disclosure violations
Sentiment note

Company missed Q1 2026 revenue consensus estimates, reported lower deliveries than prior year, failed to fulfill committed unit deliveries, lowered full-year revenue outlook, and experienced a 31.7% stock price decline. These factors indicate operational underperformance and potential disclosure issues that triggered a fraud investigation.

Negative Benzinga • Law Offices Of Frank R. Cruz
Securities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz is investigating Alphatec Holdings for potential federal securities law violations. On May 5, 2026, Alphatec reported Q1 2026 results that missed revenue consensus estimates, with lower deliveries and reduced full-year EOS revenue outlook. The company cited installation timing challenges and unfulfilled unit commitments. The stock fell 31.7% to $6.99 on May 6, 2026.

ATEC securities fraud investigation Alphatec Holdings Q1 2026 earnings miss revenue decline shareholder losses EOS installation delays
Sentiment note

Company missed revenue consensus estimates, reported lower deliveries year-over-year, reduced full-year guidance, disclosed unfulfilled unit commitments, faces securities fraud investigation, and experienced a significant 31.7% stock price decline following earnings announcement.

Negative GlobeNewswire Inc. • Kirby Mcinerney Llp
ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.

Law firm Kirby McInerney LLP is investigating potential securities law violations by Alphatec Holdings following the company's May 5, 2026 earnings report. Alphatec disclosed Q1 2026 revenue of $192 million with EOS platform revenue of $14 million, missing internal expectations due to installation delays and unfulfilled unit commitments. The company reduced its full-year EOS revenue guidance from $85 million to $77 million. The stock declined 32% from $10.23 to $6.99 following the announcement.

ATEC securities investigation earnings miss revenue guidance reduction EOS platform installation delays stock decline federal securities laws
Sentiment note

Company missed Q1 revenue expectations, reduced full-year EOS revenue guidance by $8 million, disclosed execution issues with product installations, and experienced a significant 32% stock price decline following earnings announcement. These factors indicate operational challenges and investor disappointment.

Negative Benzinga • Glancy Prongay Wolke & Rotter Llp
Securities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

A securities fraud investigation has been announced against Alphatec Holdings, Inc. following the company's May 5, 2026 earnings miss. Alphatec reported lower-than-expected revenue, reduced full-year EOS revenue outlook, and disclosed installation timing challenges and unfulfilled unit commitments. The stock fell 31.7% to $6.99 per share on May 6, 2026.

ATEC securities fraud investigation earnings miss revenue guidance reduction shareholder lawsuit stock decline installation delays unfulfilled commitments
Sentiment note

The company faces a securities fraud investigation following significant earnings misses, reduced full-year guidance, operational challenges with EOS installations, and unfulfilled unit commitments. The 31.7% stock price decline reflects severe investor losses and loss of confidence in management's execution and transparency.

Negative Benzinga • Law Offices Of Frank R. Cruz
Securities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announced a securities fraud investigation into Alphatec Holdings, Inc. following the company's May 5, 2026 earnings miss. Alphatec reported lower-than-expected revenue, reduced full-year 2026 guidance, and disclosed challenges with EOS installation timing and unfulfilled unit commitments. The stock fell 31.7% to $6.99 per share on May 6, 2026.

ATEC securities fraud investigation Alphatec Holdings earnings miss revenue decline guidance reduction shareholder losses stock price decline
Sentiment note

The company missed consensus revenue estimates, reduced full-year 2026 EOS revenue guidance, reported lower deliveries and revenue recognition, disclosed installation timing challenges, and failed to fulfill committed unit orders. Additionally, a securities fraud investigation was announced, and the stock experienced a significant 31.7% price decline.

Positive The Motley Fool • Jonathan Ponciano
Alphatec Stock Up 126% as CEO Sells $2 Million in Shares -- Here's What Investors Should Know

Alphatec Holdings CEO Miles Patrick sold 100,000 shares worth $2.1 million in a prearranged transaction, reducing his direct holdings by 6.82%. Despite the insider sale, the article maintains a bullish outlook, noting the company's strong operational momentum with 30% YoY revenue growth, expanding margins, and raised full-year guidance. The CEO retains over 5.1 million shares, maintaining alignment with shareholders.

ATEC insider selling medical devices spinal surgery revenue growth EBITDA expansion CEO stock sale Rule 10b5-1 plan
Sentiment note

Despite the CEO's insider sale, the article emphasizes strong fundamentals including 30% YoY revenue growth, 31% surgical revenue growth, 800+ basis points EBITDA margin expansion, and raised full-year guidance. The sale is characterized as a routine, prearranged transaction that doesn't signal a change in conviction. The stock has gained 126% over 12 months, and the CEO retains substantial holdings, maintaining shareholder alignment.

Neutral The Motley Fool • Robert Izquierdo
Is Alphatec Stock a Buy or Sell After Its COO Dumped Nearly 20,000 Shares?

Alphatec Holdings COO Scott Lish sold 19,900 shares worth approximately $390,836 on December 16, 2025. Despite the insider sale, the article suggests this is not a red flag as Lish retained over 640,000 shares. The sale occurred during a strong price run-up (127% annual return), with the stock's P/S ratio doubling to over 4x. While the company shows solid fundamentals with 30% YoY revenue growth and improving margins, the analyst recommends waiting for a price pullback before buying.

ATEC insider selling medical technology spinal surgery stock valuation profitability trajectory direct-to-surgeon strategy
Sentiment note

The company demonstrates strong operational fundamentals (30% YoY revenue growth, 70% gross margin, improving operating losses) and the insider's sale is characterized as non-concerning given his substantial remaining stake. However, the stock's valuation has become stretched (P/S ratio of 4x, up from 2.4x), and the analyst explicitly recommends waiting for a price pullback before investing, suggesting current valuations do not justify entry despite positive business metrics.

Positive The Motley Fool • Sara Appino
Alphatec Executive Unloads 100,000 Shares for $2 Million on Earnings Beat

Alphatec Holdings' HR executive Craig Hunsaker sold 100,000 shares worth $2 million, representing 7.2% of his stake. The company has seen strong quarterly performance with 30% revenue growth and is approaching positive free cash flow in 2025.

ATEC insider trading spinal surgery medical technology stock sale revenue growth
Sentiment note

Strong quarterly results with 30% revenue growth, 26% growth in new surgeon users, approaching positive free cash flow, and 118% year-to-date stock price increase. 10 out of 11 analysts recommend buying the stock with an average price target representing 10% upside.

Unknown Benzinga • Benzinga Insights
Expert Outlook: Alphatec Holdings Through The Eyes Of 7 Analysts

Alphatec Holdings (NASDAQ:ATEC) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 4 0 0 0 0 3M Ago 2 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $21.57, a high estimate of $25.00, and a low estimate of $19.00. Witnessing a positive shift, the current average has risen by 5.22% from the previous average price target of $20.50. Exploring Analyst Ratings: An In-Depth Overview An in-depth analysis of recent analyst actions unveils how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $23.00 - David Saxon Needham Raises Buy $23.00 $22.00 Caitlin Cronin Canaccord Genuity Maintains Buy $25.00 - David Saxon Needham Raises Buy $22.00 $19.00 David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

ATEC Analyst Ratings
Unknown Zacks Investment Research • Zacks Equity Research
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 28.57% and 7.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

KIDS ATEC
Unknown Benzinga • Benzinga Insights
A Closer Look at 4 Analyst Recommendations For Alphatec Holdings

4 analysts have shared their evaluations of Alphatec Holdings (NASDAQ:ATEC) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.0, a high estimate of $20.00, and a low estimate of $18.00. Witnessing a positive shift, the current average has risen by 18.75% from the previous average price target of $16.00. Diving into Analyst Ratings: An In-Depth Exploration The standing of Alphatec Holdings among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - David Saxon Needham Raises Buy $18.00 $16.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

ATEC Analyst Ratings
Unknown Benzinga • Benzinga Insights
Critical Insights From Alphatec Holdings Analyst Ratings: What You Need To Know

Analysts' ratings for Alphatec Holdings (NASDAQ:ATEC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $19.0, along with a high estimate of $20.00 and a low estimate of $18.00. This upward trend is evident, with the current average reflecting a 18.75% increase from the previous average price target of $16.00. Investigating Analyst Ratings: An Elaborate Study In examining recent analyst actions, we gain insights into how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - David Saxon Needham Raises Buy $18.00 $16.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related ...Full story available on Benzinga.com

ATEC Analyst Ratings
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal